Searcharxiv⌕ Search
Home/Archive/arXiv

arXiv · 2609.22419

County-Level Heterogeneity in Opioid Harm Reduction and Treatment Effects: A Simulation Modeling Analysis

Abdulrahman A. Ahmed·M. Amin Rahimian·Qiushi Chen·Praveen Kumar
View original source ↗Read source document ↗Export metadata ↓

Abstract

Opioid overdose deaths remain a severe public health crisis in the US, with heterogeneous burden across counties that differ in epidemic trajectory, baseline resources, and local context. While harm reduction through naloxone distribution and buprenorphine treatment are both evidence-based strategies, limited information on county-level effects hinders the ability of policymakers to prioritize resources across counties. We developed a simulation model of opioid use disorder (OUD), calibrated separately to six Pennsylvania counties spanning large urban (Allegheny, Philadelphia), intermediate-sized (Erie, Dauphin), and rural (Clearfield, Columbia) settings. We projected county-specific overdose mortality trajectories under three levels of increase in buprenorphine dispensing and naloxone distribution (10%, 20%, and 30% above each county's baseline), over a five-year horizon from 2025 to 2029. A 30% increase in naloxone distribution above observed county baseline levels was projected to reduce 2029 overdose deaths by approximately 70% (95% uncertainty interval, UI: 55-81%) in Allegheny County, 11% (95% UI:4-17%) in Erie County, and 28% (95% UI:2-64%) in Clearfield County. Projected reductions in overdose deaths from increasing buprenorphine were consistently smaller (10%-23%), except that in Erie buprenorphine produced larger projected reduction by 20% vs 11% for naloxone. Heterogeneity in naloxone responsiveness was strongly associated with each county's historical naloxone dispensing variability. The same proportional increase in naloxone distribution yields substantially different projected mortality reductions across counties depending on each county's baseline distribution history, a pattern invisible from mortality statistics alone. County-level context is important for informing harm reduction and treatment prioritization at the county level.

Explore related subjects

stat.APcs.SIphysics.soc-ph

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Abdulrahman A. Ahmed, M. Amin Rahimian, Qiushi Chen, Praveen Kumar. 2026-09-18. County-Level Heterogeneity in Opioid Harm Reduction and Treatment Effects: A Simulation Modeling Analysis. https://arxiv.org/abs/2609.22419

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Geospatial Foundation Models Capture Health-Relevant Dimensions of Place Beyond Conventional Social Risk Indices

Area-based social risk indices summarize residents' socioeconomic conditions but incompletely capture physical features of place that may affect health. We evaluated whether numerical representations of physical place produced by four geospatial foundation model families from 2022 satellite data explained residual variance in tract-level associations between the Area Deprivation Index, Social Deprivation Index, and Social Vulnerability Index with health outcomes. We used LightGBM to predict variables from the American Community Survey and 40 chronic disease and health-behavior outcomes from CDC PLACES across 82,646 census tracts in the contiguous United States, evaluating performance across 10 held-out states. Among survey variables, models were moderately predictive of some variables including housing type (R-squared up to 0.54) but weak for disability, unemployment, and income disparity. For health outcomes, models explained up to 54% of variance left unexplained by social risk indices, with the largest gains for annual checkups, arthritis, and high blood pressure. Mean total variance explained by geospatial foundation models across the 40 health-related outcomes increased from 0.31 in the smallest tract-size decile to 0.39 in the largest. Geospatial foundation models capture health-relevant features of place not represented by conventional social risk indices and may usefully augment them in epidemiological analyses.

stat.AP↗
arXiv2026

Transporting summary measures of relative effects from randomised trials to the treated patient population: an application to breast cancer endocrine therapy

Randomised trials often report relative treatment effects, such as risk ratios and hazard ratios, for trial populations. Clinical decision-making, however, often benefits from estimates of absolute treatment effects in the population eligible for treatment. Trial participants may not represent this target population well, and restrictions on access to individual participant trial data can further complicate absolute effect estimation. Routine care data are often representative of the target population but may be subject to uncontrolled confounding. We consider estimation of the average treatment effect on the treated (ATT), an absolute measure, by combining a representative sample of treated routine care patients with summary measures (i.e., estimated risk or hazard ratios) from either a randomised trial or a meta-analysis of trials. Under marginal or conditional transportability assumptions, the ATT is shown to be identifiable. The implications of collapsibility of the effect measure on transportability are discussed, and plug-in estimators of the ATT are presented. Simulation studies are used to assess finite sample performance of the estimators in a range of settings. The proposed methods are applied to estimate the ATT of endocrine therapy on 15-year breast cancer mortality using results from a meta-analysis of randomised trials and England's National Disease Registration Service.

stat.AP↗
arXiv2026

Overcoming Model Misspecification in Bayesian Inference of Molecular Signalling Networks

Bayesian inference of molecular signalling networks usually relies on tractability of the marginal likelihood, enabling the set of possible networks to be efficiently explored. As such, linear models with independent errors and conjugate priors are routinely used. However, the dynamics of molecular signalling are nonlinear, and relevant confounders are often unobserved; failure to account for these complexities will almost certainly lead to over-confident inferences in the standard Bayesian framework. To confront this reality, we develop a post-Bayesian approach to inference of molecular signalling networks, guided by the principle that uncertainty should not vanish when the statistical model is misspecified, even in the infinite-data limit. Technically, we extend the predictively-oriented (PrO) posterior of McLatchie et al. (2025) to the setting of latent variable models, empirically investigating the properties of PrO posteriors in the challenging network inference context.

stat.AP↗